Michelle Martinot-Peignoux

Author

Also Known As

M Martinot-Peignoux, M Martinot‐Peignoux, M. Martinot-Peignoux, M. Martinot‐Peignoux, M.M. Martinot-Peignoux, Michelle Martinot-Peignoux

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Beaujon Université Paris Cité Assistance Publique – Hôpitaux de Paris Délégation Paris 7

About

Michelle Martinot-Peignoux is an author at Inserm specializing in hepatitis, medicine, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.9K
2	Hepatology	15	18	1.8K
3	Immunology	13	14	1.3K
4	Epidemiology	3	3	222
5	Medical Laboratory Science	1	1	21

Michelle Martinot-Peignoux

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients # Rami Moucari, Vincent Mackiewicz, Olivier Lada, Hepatology	2008	480
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis A.C. Cardoso, Rami Moucari, C. Figueiredo-Mendes, Journal of Hepatology HepatologyHepatitis CRibavirin TherapyViral HepatitisHepatitis C Patients	2010	333
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up Corinne Castelnau, Frédéric Le Gal, Marie–Pierre Ripault, Hepatology Hepatitis Delta VirusImmunologyHepatitis BInterferon AlphaAutoimmune Liver Disease	2006	237
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers Michelle Martinot-Peignoux, Nathalie Boyer, Magalie Colombat, Journal of Hepatology HepatologyViral HepatitisLiver HistologyImmunologyHepatitis B	2002	235
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study Rami Moucari, Anneke Korevaar, Olivier Lada, Journal of Hepatology Hepatitis DVaccinationHepatologyHigh RatesViral Hepatitis	2009	185
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C Tarik Asselah, Simon De Muynck, Philippe Broët, Journal of Hepatology Il28b PolymorphismAutoimmune DiseaseHepatitis CHepatologyViral Hepatitis	2011	182
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA Michelle Martinot-Peignoux, Nathalie Boyer, Dominique Cazals‐Hatem, Hepatology	2001	164
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study Christopher Payan, F Roudot-Thoraval, Patrick Marcellin, Journal of Viral Hepatitis	2005	143
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy Michelle Martinot-Peignoux, F Roudot-Thoraval, Isabelle Mendel, Journal of Viral Hepatitis Hepatitis DHcv GenotypeDiagnostic VirologyHepatologyHepatitis C	1999	120
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients Michelle Martinot-Peignoux, Roberto José de Carvalho‐Filho, Martine Lapalus, Journal of Hepatology FibrosisHepatologyAutoimmune DiseaseViral HepatitisImmunology	2013	114

Page 1